David Dean Halbert's most recent trade in Caris Life Sciences Inc. - Ordinary Shares - Class A was a trade of 40,712 Common Stock done at an average price of $15.3 . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caris Life Sciences Inc (Class A) | David Dean Halbert | Director, See Remarks, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.25 per share. | 15 May 2026 | 40,712 | 2,574,533 | - | 15.3 | 620,858 | Common Stock |
| Caris Life Sciences Inc (Class A) | David Dean Halbert | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 320,112 | 2,615,245 | - | 0 | Common Stock |